0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Neurology & clinical neurophysiology

Buy Now

Muscular Dystrophy - Methods and Protocols (Paperback, Softcover reprint of hardcover 1st ed. 2001) Loot Price: R3,262
Discovery Miles 32 620
Muscular Dystrophy - Methods and Protocols (Paperback, Softcover reprint of hardcover 1st ed. 2001): Katherine M D Bushby,...

Muscular Dystrophy - Methods and Protocols (Paperback, Softcover reprint of hardcover 1st ed. 2001)

Katherine M D Bushby, Louise V.B Anderson

Series: Methods in Molecular Medicine, 43

 (sign in to rate)
Loot Price R3,262 Discovery Miles 32 620 | Repayment Terms: R306 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

The term "muscular dystrophy" (MD) describes a group of primary genetic disorders of muscle that often have a distinctive and recognizable clinical p- notype, accompanied by characteristic, but frequently not pathognomonic, pathological features. Research into the molecular basis of the MDs by a c- bination of positional cloning and candidate gene analysis has provided the basis for a reclassification of these disorders, with genetic and protein data augmenting traditional clinically based nomenclature. These findings have brought insights into the molecular pathogenesis of MD, with an increasing number of potential pathways involved in arriving at a dystrophic phenotype. Some common themes can be recognized, however, including the involvement of five members of the dystrophin-associated complex (dystrophin and four sarcoglycans) in different types of MD, and the involvement of two nuclear envelope proteins in producing an Emery-Dreifuss MD phenotype. Other d- ease-associated genes appear to cause MD in a completely unrelated way, such as the involvement of calpain 3 in a form of limb-girdle muscular dystrophy. Section 1 of Muscular Dystrophy: Methods and Protocols reviews tra- tional strategies used to identify MDs. Meantime, techniques developed as a result of the research strategies described previously have become an integral part of the management of many patients with MD and their families, and these techniques are addressed in Sections 2 (DNA-based tests) and 3 (p- tein-based analyses). The continued effort to translate this enhanced und- standing into a molecular cure or treatment for MD is reviewed in Section 4.

General

Imprint: HumanaPress
Country of origin: United States
Series: Methods in Molecular Medicine, 43
Release date: November 2010
First published: 2001
Editors: Katherine M D Bushby • Louise V.B Anderson
Dimensions: 229 x 152 x 26mm (L x W x T)
Format: Paperback
Pages: 458
Edition: Softcover reprint of hardcover 1st ed. 2001
ISBN-13: 978-1-61737-140-0
Categories: Books > Medicine > Clinical & internal medicine > Neurology & clinical neurophysiology
LSN: 1-61737-140-8
Barcode: 9781617371400

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners